Skip to main content
Home
Zeitschriften
Zeitungen
Podcast
Gesundheitspolitik
Praxis
Allerlei
Jobs
Fachgebiete
Allgemeinmedizin Anästhesiologie & Intensivmedizin Apotheke Augenheilkunde Chirurgie Dermatologie Gynäkologie und Geburtshilfe HNO Innere Medizin Kinder & Jugendheilkunde Neurologie & Psychiatrie Orthopädie & Unfallchirurgie Pflege Urologie Zahnmedizin
Subfächer Innere Medizin
Diabetologie Gastroenterologie Infektiologie Kardiologie Onkologie und Hämatologie Pneumologie Rheumatologie
Fortbildungen
Überblick Fortbildungen DFP-Literaturstudium-Artikel DFP-Webcast Fortbildungen DFP-Podcasts
Erweiterte Suche
Anmelden
nach oben
memo - Magazine of European Medical Oncology
Erschienen in:

07.09.2017 | editorial

Development of chemotherapeutics in oncology: is there anything new?

verfasst von: Holger Rumpold, Thomas Winder

Erschienen in: memo - Magazine of European Medical Oncology | Ausgabe 3/2017

Einloggen, um Zugang zu erhalten

Excerpt

In a decade where the dynamic development of targeted therapies and modulation of the immune system for treating cancer has dramatically changed and dominates the armamentarium of an oncologist, the topic the authors of this minireview series have been confronted was challenging: is there anything new in the development of classical cytostatic drugs and their indications? …
Nächster Artikel An Austrian view of the 2017 consensus for the treatment of early breast cancer
Metadaten
Titel
Development of chemotherapeutics in oncology: is there anything new?
verfasst von
Holger Rumpold
Thomas Winder
Publikationsdatum
07.09.2017
Verlag
Springer Vienna
Erschienen in
memo - Magazine of European Medical Oncology / Ausgabe 3/2017
Print ISSN: 1865-5041
Elektronische ISSN: 1865-5076
DOI
https://doi.org/10.1007/s12254-017-0350-4

Weitere Artikel der Ausgabe 3/2017

Chemotherapies and future directions in metastatic colorectal cancer

  • short review

An Austrian view of the 2017 consensus for the treatment of early breast cancer

  • editorial

Local therapies for breast cancer

  • Open Access
  • short review

Activity of panobinostat in combination with bortezomib and dexamethasone in advanced, proteasome inhibitor refractory multiple myeloma

  • case report

Cross-over comparison and new chemotherapy regimens in metastatic pancreatic cancer

  • Open Access
  • short review

New chemotherapies in gastric adenocarcinoma

  • short review